This study investigates the capabilities of AI tools including ChatGPT for conducting pricing and re...
Read moreEffective pricing and market access (PMA) teams are vital for pharmaceutical companies to secure rei...
Read moreThe Saudi Food & Drug Authority (SFDA) released guidelines for Economic Evaluation Studies to assess...
Read moreGermany's new Medicines Research Act allows confidential rebates for pharma companies, but recent am...
Read moreWe explore CAR T-cell therapy challenges, regulatory approvals, market growth, pricing models, and a...
Read moreThe study explores the complexities of pricing and reimbursement for multi-indication products in th...
Read moreThe World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar...
Read moreThis expert article focusses on the new proportionate approach, and the international recognition pr...
Read moreWe've updated our 2019 analysis which compares the annual and lifetime treatment costs of the 10 mos...
Read moreOur study compares and contrasts the evaluation and reimbursement pathways for digital therapeutics ...
Read more